ReviewPharmacology & therapeutics2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities.
Filipa Lynce et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled ittrialcites it